Establishing an outpatient CDI program can have substantial benefits. Recently, an outpatient CDI review project demonstrated there were many documentation improvement opportunities at a large family practice/internal medicine physician clinic.
A proposed rule that would expand the use of prior authorization and step therapy for Part D and Medicare Advantage beneficiaries has earned criticism from patient advocacy groups and praise from pharmacy groups.
This week’s Medicare updates include an FAQ on the new price transparency rule for 2019, an update to the Medicare Benefit Policy Manual to include new payment policies for rural health clinics, a fact sheet on the Value-Based Purchasing Program for FY 2019, and more!
Q: If a patient participating in a clinical trial is allergic to one of the drugs used in the trial, how do we report the drug that is used as a substitute?
This week’s Medicare updates include a proposed rule regarding changes to the Medicare Advantage program regulations and Prescription Drug Benefit program, a review of hospital wage data to determine vulnerabilities in the hospital wage index system, the Fall 2018 semiannual report to Congress, and more!
